Back

Immediate vs staged in-hospital vs staged out-of-hospital complete revascularization in STEMI patients with multivessel disease: a network meta-analysis of randomized trials

28 August 2026 (12:30 - 12:40)
Organised by: Logo
Congress Presentation Part of: Complex acute coronary syndromes phenotypes: risk stratification and management strategies ST-Elevation Myocardial Infarction (STEMI) ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Giovanni Martino

University of Calabria, Rende (Italy)

3 More presentations in this session

Presentation thumbnail
Ischemic ECG patterns at admission identify Takotsubo patients at increased risk of mortality
Doctor A. Agam (Aalborg, DK)
Abstract Slides Video
Presentation thumbnail
Upfront percutaneous coronary intervention versus conservative management in spontaneous coronary artery dissection: long-term outcomes from the Australian-New Zealand SCAD registry
Doctor P. Pender (Liverpool, AU)
Abstract Slides Video
Presentation thumbnail
Artificial intelligence–enabled ECG-identification of occlusive myocardial infarction in non-ST-elevation acute coronary syndrome and association with infarct size and survival
Associate Professor M. Unterhuber (Bolzano, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Complex acute coronary syndromes phenotypes: risk stratification and management strategies
Video

The Event

Event poster

ESC Congress 2026

28 August 2026 12:30 CET
You may be interested in
thumbnail
Congress Presentation
Clinical outcomes of immediate complete versus staged revascularization among STEMI patients and multivessel disease without cardiogenic shock: a meta-analysis.
1 September 2024
thumbnail
Congress Session
Non-obstructive coronary disease: what's new in assessment and management
30 August 2025
thumbnail
Congress Presentation
Discussant review - OPTION-STEMI
31 August 2025
thumbnail
Congress Presentation
Percutaneous coronary revascularisation in multivessel disease associated with NSTE-ACS: what is the ideal strategy?
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources